XBiotech (XBIT) EV to FCF (2015 - 2025)

XBiotech has reported EV to FCF for 11 years, with the latest figure at 2.29 in Q4 2025.

• On a quarterly basis, EV to FCF fell 70.94% year-over-year to 2.29 in Q4 2025; TTM through Dec 2025 was 1.31, a 19.08% decrease from a year earlier, with the FY2025 full-year figure at 1.31, down 19.08% from the prior year.
• EV to FCF was 2.29 for Q4 2025 at XBiotech, down from 15.18 in the prior quarter.
• The five-year high for EV to FCF was 234.56 in Q1 2021, with the low at 45.55 in Q4 2021.
• Average EV to FCF over 5 years is 20.09, with a median of 8.14 recorded in 2024.
• The largest YoY upside for EV to FCF was 10145.39% in 2021 against a maximum downside of 180.17% in 2021.
• Over 5 years, EV to FCF stood at 45.55 in 2021, then surged by 173.69% to 33.57 in 2022, then tumbled by 34.28% to 22.06 in 2023, then plunged by 64.25% to 7.89 in 2024, then plunged by 70.94% to 2.29 in 2025.
• The last three EV to FCF figures came in at 2.29 (Q4 2025), 15.18 (Q3 2025), and 10.33 (Q2 2025), per Business Quant data.